AR
Advisory Research Portfolio holdings
AUM
$651M
1-Year Return
25.02%
This Quarter Return
+11.28%
1 Year Return
+25.02%
3 Year Return
+143.09%
5 Year Return
+422.22%
10 Year Return
+498.78%
AUM
$1.06B
AUM Growth
+$40.2M
(+3.9%)
Cap. Flow
-$24.6M
Cap. Flow
% of AUM
-2.32%
Top 10 Holdings %
Top 10 Hldgs %
38.82%
Holding
432
New
78
Increased
76
Reduced
169
Closed
68
Top Buys
| 1 |
Diamondback Energy
FANG
|
$57.4M |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
$26.8M |
| 3 |
Ovintiv
OVV
|
$9.71M |
| 4 |
iShares Russell 2000 ETF
IWM
|
$5.37M |
| 5 |
CHX
ChampionX
CHX
|
$3.38M |
Top Sells
| 1 |
DEN
Denbury Inc.
DEN
|
$24.7M |
| 2 |
EXE
Expand Energy Corporation Common Stock
EXE
|
$17M |
| 3 |
Antero Resources
AR
|
$12.2M |
| 4 |
Accenture
ACN
|
$10.3M |
| 5 |
Home Depot
HD
|
$8.82M |
Sector Composition
| 1 | Energy | 37% |
| 2 | Healthcare | 10.56% |
| 3 | Technology | 9.86% |
| 4 | Financials | 9.12% |
| 5 | Consumer Discretionary | 8.61% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Xenon Pharmaceuticals
XENE
$3.02B
| $1.29M | 0.12% |
32,731
-3,707
| -10% | -$146K |
|
127
Privia Health
PRVA
$2.86B
| $1.25M | 0.12% |
54,933
-43,396
| -44% | -$986K |
|
128
Thryv Holdings
THRY
$549M
| $1.24M | 0.12% |
+65,055
| New | +$1.24M |
|
129
Oaktree Specialty Lending
OCSL
$1.23B
| $1.23M | 0.12% |
59,830
-3,715
| -6% | -$76.6K |
|
130
Immunocore
IMCR
$1.87B
| $1.22M | 0.11% |
21,401
-5,770
| -21% | -$329K |
|
|
DNB
131
DELISTED
Dun & Bradstreet
DNB
| $1.22M | 0.11% |
99,615
-4,160
| -4% | -$51K |
|
132
Portillo's
PTLO
$490M
| $1.22M | 0.11% |
74,771
-25,965
| -26% | -$424K |
|
133
Arcos Dorados Holdings
ARCO
$1.47B
| $1.2M | 0.11% |
143,657
+8,595
| +6% | +$71.9K |
|
134
American Express
AXP
$227B
| $1.19M | 0.11% |
8,062
| – | – |
|
135
Lam Research
LRCX
$130B
| $1.16M | 0.11% |
27,570
-30
| -0.1% | -$1.26K |
|
|
CBRG
136
DELISTED
Chain Bridge I Class A Ordinary Shares
CBRG
| $1.15M | 0.11% |
112,080
-57,130
| -34% | -$587K |
|
137
TechTarget
TTGT
$403M
| $1.15M | 0.11% |
26,135
-555
| -2% | -$24.5K |
|
138
Green Brick Partners
GRBK
$3.2B
| $1.15M | 0.11% |
+47,301
| New | +$1.15M |
|
139
Main Street Capital
MAIN
$5.95B
| $1.14M | 0.11% |
30,834
-731
| -2% | -$27K |
|
140
Fortune Brands Innovations
FBIN
$7.3B
| $1.14M | 0.11% |
19,933
-4,611
| -19% | -$263K |
|
141
Option Care Health
OPCH
$4.72B
| $1.14M | 0.11% |
37,812
-22,623
| -37% | -$681K |
|
142
WisdomTree International LargeCap Dividend Fund
DOL
$658M
| $1.14M | 0.11% |
25,850
| – | – |
|
143
Thermo Fisher Scientific
TMO
$186B
| $1.13M | 0.11% |
2,048
-36
| -2% | -$19.8K |
|
144
Vanguard Mid-Cap ETF
VO
$87.3B
| $1.12M | 0.11% |
5,505
| – | – |
|
145
Hercules Capital
HTGC
$3.49B
| $1.12M | 0.11% |
84,799
-4,459
| -5% | -$58.9K |
|
146
STAAR Surgical
STAA
$1.38B
| $1.12M | 0.11% |
23,077
-39,905
| -63% | -$1.94M |
|
|
INTE
147
DELISTED
Integral Acquisition Corporation 1 Class A Common Stock
INTE
| $1.11M | 0.1% |
109,970
-5,970
| -5% | -$60.4K |
|
148
Sixth Street Specialty
TSLX
$2.32B
| $1.11M | 0.1% |
62,195
-7,068
| -10% | -$126K |
|
|
DCBO
149
Docebo
DCBO
$896M
| $1.11M | 0.1% |
+33,361
| New | +$1.11M |
|
150
Ventyx Biosciences
VTYX
$180M
| $1.1M | 0.1% |
33,600
+1,874
| +6% | +$61.4K |
|